imatinib mesylate has been researched along with Agranulocytosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amital, H; Khouri, S; Kotliroff, A; Lishner, M | 1 |
| Hino, M; Koh, KR; Nakamae, H; Nakane, T; Nakao, T; Terada, Y; Yamane, T; Yoshida, N | 1 |
2 other study(ies) available for imatinib mesylate and Agranulocytosis
| Article | Year |
|---|---|
Imatinib-lnduced agranulocytosis in a patient with chronic myelogenous leukemia in remission.
Topics: Adult; Agranulocytosis; Antineoplastic Agents; Benzamides; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Piperazines; Protein Kinase Inhibitors; Pyrimidines | 2008 |
[Chronic myelogenous leukemia complicated by drug-induced agranulocytosis].
Topics: Aged; Agranulocytosis; Benzamides; Butylscopolammonium Bromide; Colonoscopy; Female; Flumazenil; Granulocyte Colony-Stimulating Factor; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Neutropenia; Piperazines; Premedication; Pyrimidines; Treatment Outcome | 2011 |